In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

P. Musk, S. Szmania, A. Galloway, K. Johnson, A. Scott, S. Guttman, K. Bridges, M. Bruorton, J. Gatlin, J. V. Garcia, L. Lamb, K. Y. Chiang, T. Spencer, J. Henslee-Downey, F. Van Rhee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Use of a partially mismatched related donor (PMRD) is an option for patients who require allogeneic transplantation but do not have a matched sibling or unrelated donor. Epstein-Barr virus (EBV)-induced lymphoma is a major cause of mortality after PMRD transplantation. In this study, we present a clinical grade culture system for donor-derived EBV-specific cytotoxic T cells (CTLs) that do not recognize haplo-identical recipient cells. The EBV-specific CTLs were tested for cytolytic specificity and other functional properties, including ability to transgress into tissues, propensity for apoptosis, degree of clonality, stability of dominant T-cell clones, and Tc and Th phenotypes. The EBV-specific CTLs were routinely expanded to greater than 80 × 106 over a period of 5 weeks, which is sufficient for clinical application. A CD8+ phenotype predominated, and the CTLs were highly specific for donor lymphoblastoid cell lines (LCLs) without killing of recipient targets or K562. Vβ spectratyping showed an oligoclonal population that was stable on prolonged culture. The EBV-specific CTLs were activated (D-related human leukocyte antigen [HLA-DR+], L-selectin+/-) and of memory phenotype (CD45RO+). Expression of the integrin VLA-4 suggested that these CTLs could adhere to endothelium and migrate into tissues. The Bcl-2 message was upregulated, which may protect the CTLs from the apoptosis. The first demonstration of overexpression of bcl-2 in human memory CTLs. In addition, we show that lymphoblastoid cell lines used to generate CTLs are readily genetically modified with recombinant lentivirus, indicating that genetically engineered antigen presentation is feasible.

Original languageEnglish (US)
Pages (from-to)312-322
Number of pages11
JournalJournal of Immunotherapy
Volume24
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Stem Cell Transplantation
Human Herpesvirus 4
T-Lymphocytes
Tissue Donors
Phenotype
In Vitro Techniques
Apoptosis
Integrin alpha4beta1
L-Selectin
Cell Line
Unrelated Donors
Lentivirus
Aptitude
Homologous Transplantation
Antigen Presentation
Population Dynamics
HLA-DR Antigens
HLA Antigens
Integrins
Endothelium

Keywords

  • Cytotoxic T lymphocytes
  • Epstein-Barr virus
  • Haplo-identical BMT

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Immunology

Cite this

In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. / Musk, P.; Szmania, S.; Galloway, A.; Johnson, K.; Scott, A.; Guttman, S.; Bridges, K.; Bruorton, M.; Gatlin, J.; Garcia, J. V.; Lamb, L.; Chiang, K. Y.; Spencer, T.; Henslee-Downey, J.; Van Rhee, F.

In: Journal of Immunotherapy, Vol. 24, No. 4, 2001, p. 312-322.

Research output: Contribution to journalArticle

Musk, P, Szmania, S, Galloway, A, Johnson, K, Scott, A, Guttman, S, Bridges, K, Bruorton, M, Gatlin, J, Garcia, JV, Lamb, L, Chiang, KY, Spencer, T, Henslee-Downey, J & Van Rhee, F 2001, 'In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation', Journal of Immunotherapy, vol. 24, no. 4, pp. 312-322. https://doi.org/10.1097/00002371-200107000-00007
Musk, P. ; Szmania, S. ; Galloway, A. ; Johnson, K. ; Scott, A. ; Guttman, S. ; Bridges, K. ; Bruorton, M. ; Gatlin, J. ; Garcia, J. V. ; Lamb, L. ; Chiang, K. Y. ; Spencer, T. ; Henslee-Downey, J. ; Van Rhee, F. / In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation. In: Journal of Immunotherapy. 2001 ; Vol. 24, No. 4. pp. 312-322.
@article{9c8fdf744328435ab83f8d772cdef581,
title = "In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation",
abstract = "Use of a partially mismatched related donor (PMRD) is an option for patients who require allogeneic transplantation but do not have a matched sibling or unrelated donor. Epstein-Barr virus (EBV)-induced lymphoma is a major cause of mortality after PMRD transplantation. In this study, we present a clinical grade culture system for donor-derived EBV-specific cytotoxic T cells (CTLs) that do not recognize haplo-identical recipient cells. The EBV-specific CTLs were tested for cytolytic specificity and other functional properties, including ability to transgress into tissues, propensity for apoptosis, degree of clonality, stability of dominant T-cell clones, and Tc and Th phenotypes. The EBV-specific CTLs were routinely expanded to greater than 80 × 106 over a period of 5 weeks, which is sufficient for clinical application. A CD8+ phenotype predominated, and the CTLs were highly specific for donor lymphoblastoid cell lines (LCLs) without killing of recipient targets or K562. Vβ spectratyping showed an oligoclonal population that was stable on prolonged culture. The EBV-specific CTLs were activated (D-related human leukocyte antigen [HLA-DR+], L-selectin+/-) and of memory phenotype (CD45RO+). Expression of the integrin VLA-4 suggested that these CTLs could adhere to endothelium and migrate into tissues. The Bcl-2 message was upregulated, which may protect the CTLs from the apoptosis. The first demonstration of overexpression of bcl-2 in human memory CTLs. In addition, we show that lymphoblastoid cell lines used to generate CTLs are readily genetically modified with recombinant lentivirus, indicating that genetically engineered antigen presentation is feasible.",
keywords = "Cytotoxic T lymphocytes, Epstein-Barr virus, Haplo-identical BMT",
author = "P. Musk and S. Szmania and A. Galloway and K. Johnson and A. Scott and S. Guttman and K. Bridges and M. Bruorton and J. Gatlin and Garcia, {J. V.} and L. Lamb and Chiang, {K. Y.} and T. Spencer and J. Henslee-Downey and {Van Rhee}, F.",
year = "2001",
doi = "10.1097/00002371-200107000-00007",
language = "English (US)",
volume = "24",
pages = "312--322",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

AU - Musk, P.

AU - Szmania, S.

AU - Galloway, A.

AU - Johnson, K.

AU - Scott, A.

AU - Guttman, S.

AU - Bridges, K.

AU - Bruorton, M.

AU - Gatlin, J.

AU - Garcia, J. V.

AU - Lamb, L.

AU - Chiang, K. Y.

AU - Spencer, T.

AU - Henslee-Downey, J.

AU - Van Rhee, F.

PY - 2001

Y1 - 2001

N2 - Use of a partially mismatched related donor (PMRD) is an option for patients who require allogeneic transplantation but do not have a matched sibling or unrelated donor. Epstein-Barr virus (EBV)-induced lymphoma is a major cause of mortality after PMRD transplantation. In this study, we present a clinical grade culture system for donor-derived EBV-specific cytotoxic T cells (CTLs) that do not recognize haplo-identical recipient cells. The EBV-specific CTLs were tested for cytolytic specificity and other functional properties, including ability to transgress into tissues, propensity for apoptosis, degree of clonality, stability of dominant T-cell clones, and Tc and Th phenotypes. The EBV-specific CTLs were routinely expanded to greater than 80 × 106 over a period of 5 weeks, which is sufficient for clinical application. A CD8+ phenotype predominated, and the CTLs were highly specific for donor lymphoblastoid cell lines (LCLs) without killing of recipient targets or K562. Vβ spectratyping showed an oligoclonal population that was stable on prolonged culture. The EBV-specific CTLs were activated (D-related human leukocyte antigen [HLA-DR+], L-selectin+/-) and of memory phenotype (CD45RO+). Expression of the integrin VLA-4 suggested that these CTLs could adhere to endothelium and migrate into tissues. The Bcl-2 message was upregulated, which may protect the CTLs from the apoptosis. The first demonstration of overexpression of bcl-2 in human memory CTLs. In addition, we show that lymphoblastoid cell lines used to generate CTLs are readily genetically modified with recombinant lentivirus, indicating that genetically engineered antigen presentation is feasible.

AB - Use of a partially mismatched related donor (PMRD) is an option for patients who require allogeneic transplantation but do not have a matched sibling or unrelated donor. Epstein-Barr virus (EBV)-induced lymphoma is a major cause of mortality after PMRD transplantation. In this study, we present a clinical grade culture system for donor-derived EBV-specific cytotoxic T cells (CTLs) that do not recognize haplo-identical recipient cells. The EBV-specific CTLs were tested for cytolytic specificity and other functional properties, including ability to transgress into tissues, propensity for apoptosis, degree of clonality, stability of dominant T-cell clones, and Tc and Th phenotypes. The EBV-specific CTLs were routinely expanded to greater than 80 × 106 over a period of 5 weeks, which is sufficient for clinical application. A CD8+ phenotype predominated, and the CTLs were highly specific for donor lymphoblastoid cell lines (LCLs) without killing of recipient targets or K562. Vβ spectratyping showed an oligoclonal population that was stable on prolonged culture. The EBV-specific CTLs were activated (D-related human leukocyte antigen [HLA-DR+], L-selectin+/-) and of memory phenotype (CD45RO+). Expression of the integrin VLA-4 suggested that these CTLs could adhere to endothelium and migrate into tissues. The Bcl-2 message was upregulated, which may protect the CTLs from the apoptosis. The first demonstration of overexpression of bcl-2 in human memory CTLs. In addition, we show that lymphoblastoid cell lines used to generate CTLs are readily genetically modified with recombinant lentivirus, indicating that genetically engineered antigen presentation is feasible.

KW - Cytotoxic T lymphocytes

KW - Epstein-Barr virus

KW - Haplo-identical BMT

UR - http://www.scopus.com/inward/record.url?scp=17944381369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944381369&partnerID=8YFLogxK

U2 - 10.1097/00002371-200107000-00007

DO - 10.1097/00002371-200107000-00007

M3 - Article

C2 - 11565833

AN - SCOPUS:17944381369

VL - 24

SP - 312

EP - 322

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 4

ER -